Trials / Completed
CompletedNCT03257605
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
Implementation of a Pharmacist-Led Pharmacogenomics Service for the Program of All-inclusive Care for the Elderly (PHARM-GENOME-PACE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 296 (actual)
- Sponsor
- Tabula Rasa HealthCare · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate and describe the feasibility of implementing a pharmacist-led pharmacogenomics service for the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.
Detailed description
To determine if a pharmacogenomics (PGx) service can become a component of everyday practice, feasibility assessments are needed. While some researchers have begun to assess the feasibility of implementing PGx into pharmacy practice in community-based practice settings, none that we are aware have assessed such feasibility for the Program of All-inclusive Care for the Elderly (PACE). The primary objective of this feasibility study is to evaluate the processes that were involved in implementing a pharmacist-led PGx service for PACE and to describe process-related challenges and solutions associated with implementation. Secondary objectives include: describe pharmacists' roles in the implementation process; report aggregate PGx test results, including genetic variants and drug-gene interactions; and describe pharmacists' recommendations to personalize drug regimens for PACE participants and prescribers' acceptance of these recommendations.
Conditions
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-06-01
- Completion
- 2017-08-01
- First posted
- 2017-08-22
- Last updated
- 2017-08-22
Source: ClinicalTrials.gov record NCT03257605. Inclusion in this directory is not an endorsement.